Clinical Trials Browser

Phase 2 × Staging IV NSCLC × pembrolizumab × Clear all

NCT04094909 2020-02-07

Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC

Phase 2 Unknown

Staging IV NSCLC